| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |